Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 335

Acerus Announces Temporary Unavailability of NATESTO® in Canada and South Korea

Posted by fidest press agency su lunedì, 5 agosto 2019

Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) today announced that it will voluntarily replace certain NATESTO® lots released in the Canadian and South Korean markets, which is expected to cause temporary shortages in those markets.
Acerus has identified four commercial lots of NATESTO® released in the Canadian and South Korean markets that were found to be non-conforming during long-term stability studies, even though such lots were fully in-specification at the time of release. This post-release non-conformity is not harmful to the patient, but may result in difficulties in dispensing. The temporary shortage of the product in the Canadian and South Korean markets is expected to continue until the end of October 2019. Acerus has noted this shortage on the Drug Shortages Canada website and will continue to dialogue with Health Canada to identify solutions to try to minimize the disruption to patients in the affected markets.

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

 
%d blogger hanno fatto clic su Mi Piace per questo: